12:00 AM
 | 
Jul 27, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

FluMist regulatory update

AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K.
CSL Ltd. (ASX:CSL), Melbourne, Australia
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K.
Novartis AG (NYSE:NVS; SIX:NOVN), Basel,...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >